Selected Drugs Clear All
MultiCheck Results
- 4
Interactions
Avoid/Use Alternative |
||
|
Augtyro
(repotrectinib) + Idhifa
(enasidenib) |
||
Avoid/Use Alternativerepotrectinib + enasidenib avoid combo: combo may incr. or decr. repotrectinib levels, incr. risk of adverse effects or decr. efficacy (P-gp-mediated transport inhibited, hepatic metabolism induced) |
||
Monitor/Modify Tx |
||
|
Augtyro
(repotrectinib) + Onfi
(clobazam) |
||
Monitor/Modify Txrepotrectinib + clobazam monitor respiratory rate: combo may decr. repotrectinib levels, efficacy; may incr. risk of CNS and respiratory depression, psychomotor impairment (hepatic metabolism induced; additive effects) |
||
|
Idhifa
(enasidenib) + Onfi
(clobazam) |
||
Monitor/Modify Txenasidenib + clobazam monitor respiratory rate: combo may incr. clobazam and active metabolite levels, risk of CNS and respiratory depression, psychomotor impairment, other adverse effects (hepatic metabolism inhibited) |
||
Caution Advised |
||
|
Azstarys
(serdexmethylphenidate/ dexmethylphenidate) + Onfi
(clobazam) |
||
Caution Adviseddexmethylphenidate + clobazam caution advised: combo may alter seizure control (antagonistic effects, (ser)dexmethylphenidate may decr. seizure threshold) |
||
Additional Considerations |
||
|
dexmethylphenidate
in Azstarys
|
||
|
serdexmethylphenidate is the prodrug of dexmethylphenidate; similar interactions anticipated add MAO inhibitor to Interaction Check if recent (14 days) use |
||